Deutsche Bank
GENB icon

Deutsche Bank’s Generate Biomedicines GENB Stock Holding History

Deutsche Bank’s Portfolio GENB Stock Details GENB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$318K Sell
21,175
-2,960
-12% -$45.5K ﹤0.01% 2853
2026
Q2 		$407K Buy
+24,135
New +$329K ﹤0.01% 2883

Other funds holding GENB

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Savant Capital
Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Bank Pictet & Cie (Europe)
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Dynamic Advisor Solutions
Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return

Deutsche Bank's GENB Position: Q3 2026 in Review

Deutsche Bank reduced its Generate Biomedicines (GENB) stake by 12% in Q3 2026, selling an estimated $45.5K and leaving 21,175 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #2853.

Deutsche Bank first reported a position in GENB in Q2 2026 and has held it in 2 quarters since. The position peaked at $407K in Q2 2026. 35 funds tracked by Wall St. Rank hold GENB as of Q3 2026.

  • Deutsche Bank held 21,175 shares of Generate Biomedicines worth $318K as of Q3 2026.
  • Deutsche Bank sold 2,960 Generate Biomedicines shares in Q3 2026, an estimated $45.5K.
  • Generate Biomedicines made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2853 holding.
  • Deutsche Bank first reported a position in Generate Biomedicines in Q2 2026 and has held it in 2 quarters since.
  • Deutsche Bank's Generate Biomedicines position peaked at $407K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.